These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9195561)

  • 1. Characterization of interleukin-1 alpha-induced melanoma cell motility: inhibition by type I and type II receptor-blocking monoclonal antibodies.
    Dekker SK; Vink J; Bruijn JA; Mihm MC; Vermeer BJ; Byers HR
    Melanoma Res; 1997 Jun; 7(3):223-30. PubMed ID: 9195561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of interleukin 1-alpha (IL-1 alpha) or tumor necrosis factor-alpha (TNF-alpha) on motility of human melanoma cell lines on fibronectin.
    Dekker SK; Vink J; Vermeer BJ; Bruijn JA; Mihm MC; Byers HR
    J Invest Dermatol; 1994 Jun; 102(6):898-905. PubMed ID: 8006453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of integrin alpha 2 beta 1 (VLA-2) in the migration of human melanoma cells on laminin and type IV collagen.
    Etoh T; Thomas L; Pastel-Levy C; Colvin RB; Mihm MC; Byers HR
    J Invest Dermatol; 1993 May; 100(5):640-7. PubMed ID: 8491987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1-responsive and revealed the importance of ODC activity down-regulation in IL-1-induced growth inhibition.
    Yang D; Hayashi H; Hiyama Y; Takii T; Onozaki K
    J Biochem; 1995 Oct; 118(4):802-9. PubMed ID: 8576096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80).
    Daveau M; Liautard J; Gaillard JP; Hiron M; Brochier J; Lebreton JP
    Eur Cytokine Netw; 1994; 5(6):601-8. PubMed ID: 7537107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.
    Verhasselt B; Van Damme J; van Larebeke N; Put W; Bracke M; De Potter C; Mareel M
    Eur J Cell Biol; 1992 Dec; 59(2):449-57. PubMed ID: 1493810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion.
    Gebhardt C; Averbeck M; Viertel A; Kauer F; Saalbach A; Anderegg U; Simon JC
    Exp Dermatol; 2007 Aug; 16(8):636-43. PubMed ID: 17620090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 beta transduces different signals than IL-1 alpha leading to class II antigen expression on beta-insulinoma RIN-5AH cells through specific receptors.
    Vassiliadis S; Soteriadou KP; Papadopoulos GK
    J Recept Signal Transduct Res; 1997; 17(1-3):211-25. PubMed ID: 9029492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.
    Mimnaugh EG; Monti E; Sebers S; Stetler-Stevenson M; Sinha BK
    Oncol Res; 1992; 4(10):401-12. PubMed ID: 1292755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression.
    Takayama K; Yokozeki H; Ghoreishi M; Satoh T; Katayama I; Umeda T; Nishioka K
    J Invest Dermatol; 1999 Oct; 113(4):541-6. PubMed ID: 10504438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of magnesium and calcium on integrin-mediated melanoma cell migration on type IV collagen and fibronectin.
    Yoshinaga IG; Dekker SK; Mihm MC; Byers HR
    Melanoma Res; 1994 Dec; 4(6):371-8. PubMed ID: 7703716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster-function relationship of rat-antimouse P55 IL-2 receptor monoclonal antibodies. In vitro studies of the CTL-L2 mouse cell line and in vivo studies in a delayed-type hypersensitivity model in mice.
    Dantal J; Jacques Y; Soulillou JP
    Transplantation; 1991 Jul; 52(1):110-5. PubMed ID: 1858138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells.
    Lügering N; Kucharzik T; Maaser C; Kraft M; Domschke W
    Immunology; 1999 Dec; 98(4):504-9. PubMed ID: 10594681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma.
    Taetle R; Dos Santos B; Ohsugi Y; Koishihara Y; Yamada Y; Messner H; Dalton W
    J Natl Cancer Inst; 1994 Mar; 86(6):450-5. PubMed ID: 8120920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism.
    Cumberbatch M; Dearman RJ; Antonopoulos C; Groves RW; Kimber I
    Immunology; 2001 Mar; 102(3):323-30. PubMed ID: 11298831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
    Butler DM; Maini RN; Feldmann M; Brennan FM
    Eur Cytokine Netw; 1995; 6(4):225-30. PubMed ID: 8789287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha 3 beta 1 and alpha 2 beta 1 integrins in melanoma cell migration.
    Yoshinaga IG; Vink J; Dekker SK; Mihm MC; Byers HR
    Melanoma Res; 1993 Dec; 3(6):435-41. PubMed ID: 7512849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of interleukin 1 activity by cultured human melanoma cells.
    Bennicelli JL; Elias J; Kern J; Guerry D
    Cancer Res; 1989 Feb; 49(4):930-5. PubMed ID: 2783559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.